For citations:
Ovchinnikova M.V., Komissarov A.V., Abramova E.G., Kireev M.N., Ul’yanov A.Yu., Bibikov D.N., Islyaeva M.N., Nikiforov A.K. DEVELOPMENT OF PHARMACEUTICAL DOSAGE FORM OF ANTI-CHOLERA IMMUNE-ENTEROSORBENT. Problems of Particularly Dangerous Infections. 2017;(3):100-104. (In Russ.) https://doi.org/10.21055/0370-1069-2017-3-100-104
Email this article 